VIDEO: Margaret Powers, PhD, Speaks About the Impact of Obesity on Chronic Conditions

In this video, Margaret Powers, PhD, talks about obesity's impact on the management of chronic illnesses. Dr. Powers also talks about the benefits of obese patients losing 5% to 7% of body weight and working out 150 minutes a week to lower their risk of developing diabetes and other chronic conditions.

Related Videos

Related Content

Advertisement

August 1st 2025

Opportunities Remain to Improve Access for Pediatric Dermatology: Elizabeth Garcia Creighton

Laura Joszt, MA Elizabeth Garcia Creighton

August 1st 2025

Exploring Pharmaceutical Innovations, Trust, and Access With CVS Health's CMO

Brooke McCormick

On this episode of Managed Care Cast, we're talking with the chief medical officer of CVS Health about recent pharmaceutical innovations, patient-provider relationships, and strategies to reduce drug costs.

August 1st 2025

Trends in Insulin Out-of-Pocket Costs and Use Disparities, 2008-2021

Elise S. Tremblay, MD, MPH Stephanie Argetsinger, MS, MPH Fang Zhang, PhD Dennis Ross-Degnan, ScD J. Frank Wharam, MD, MPH

Given trends in cost and use, insulin out-of-pocket cost reduction policies would be more efficient if they targeted members in high-deductible health plans with savings options and low-income patients.

August 1st 2025

The Importance of Examining and Preventing Atrial Fibrillation

Maggie L. Shaw

At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.

August 1st 2025

AI, GLP-1s Among Topics to Be Discussed During ASPC Annual Meeting

Julia Bonavitacola

The American Society for Preventive Cardiology (ASPC) Congress on Cardiovascular Disease Prevention features multiple sessions on different methods of treating and preventing cardiovascular disease, including through the use of artificial intelligence (AI) and glucagon-like peptide-1 (GLP-1) receptor agonists.

August 1st 2025

Addressing SDOH in Pediatric Dermatology to Improve Outcomes

Pearl Steinzor

At the Society for Pediatric Dermatology Annual Meeting, Sarah Coates, MD, FAAD, highlights how social drivers shape pediatric skin health and how clinicians can respond.

Related Content

Advertisement

August 1st 2025

Opportunities Remain to Improve Access for Pediatric Dermatology: Elizabeth Garcia Creighton

Laura Joszt, MA Elizabeth Garcia Creighton

August 1st 2025

Exploring Pharmaceutical Innovations, Trust, and Access With CVS Health's CMO

Brooke McCormick

On this episode of Managed Care Cast, we're talking with the chief medical officer of CVS Health about recent pharmaceutical innovations, patient-provider relationships, and strategies to reduce drug costs.

August 1st 2025

Trends in Insulin Out-of-Pocket Costs and Use Disparities, 2008-2021

Elise S. Tremblay, MD, MPH Stephanie Argetsinger, MS, MPH Fang Zhang, PhD Dennis Ross-Degnan, ScD J. Frank Wharam, MD, MPH

Given trends in cost and use, insulin out-of-pocket cost reduction policies would be more efficient if they targeted members in high-deductible health plans with savings options and low-income patients.

August 1st 2025

The Importance of Examining and Preventing Atrial Fibrillation

Maggie L. Shaw

At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.

August 1st 2025

AI, GLP-1s Among Topics to Be Discussed During ASPC Annual Meeting

Julia Bonavitacola

The American Society for Preventive Cardiology (ASPC) Congress on Cardiovascular Disease Prevention features multiple sessions on different methods of treating and preventing cardiovascular disease, including through the use of artificial intelligence (AI) and glucagon-like peptide-1 (GLP-1) receptor agonists.

August 1st 2025

Addressing SDOH in Pediatric Dermatology to Improve Outcomes

Pearl Steinzor

At the Society for Pediatric Dermatology Annual Meeting, Sarah Coates, MD, FAAD, highlights how social drivers shape pediatric skin health and how clinicians can respond.